ID: ALA4588580

Max Phase: Preclinical

Molecular Formula: C24H25ClN4O3

Molecular Weight: 452.94

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(O)CC(Nc1ccc(OCCc2ccc3c(n2)NCCC3)cn1)c1ccc(Cl)cc1

Standard InChI:  InChI=1S/C24H25ClN4O3/c25-18-6-3-16(4-7-18)21(14-23(30)31)29-22-10-9-20(15-27-22)32-13-11-19-8-5-17-2-1-12-26-24(17)28-19/h3-10,15,21H,1-2,11-14H2,(H,26,28)(H,27,29)(H,30,31)

Standard InChI Key:  CLZGDNHRVKJUHQ-UHFFFAOYSA-N

Associated Targets(Human)

Integrin alpha-V/beta-6 509 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-V/beta-3 2708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 452.94Molecular Weight (Monoisotopic): 452.1615AlogP: 4.74#Rotatable Bonds: 9
Polar Surface Area: 96.37Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.76CX Basic pKa: 7.35CX LogP: 1.91CX LogD: 1.83
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.43Np Likeness Score: -0.71

References

1. Anderson NA, Campos S, Butler S, Copley RCB, Duncan I, Harrison S, Le J, Maghames R, Pastor-Garcia A, Pritchard JM, Rowedder JE, Smith CE, Thomas J, Vitulli G, Macdonald SJF..  (2019)  Discovery of an Orally Bioavailable Pan αv Integrin Inhibitor for Idiopathic Pulmonary Fibrosis.,  62  (19): [PMID:31497959] [10.1021/acs.jmedchem.9b00962]

Source